Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Director | August 14, 2026 | August 18, 2026 |
| NETFLIX INCNFLX · Entity 403 | CFO | January 02, 2019 | January 04, 2019 |
| Trade Desk, Inc.TTD · Entity 3752 | Director | May 13, 2025 | May 15, 2025 |
| Wise Group plcWSE · Entity 3428 | Director | May 08, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 229,808 |
Reported balance
After 2026-08-14 transaction · row 1
1 source rowRow 1 · 2026-08-14 · Exercise / conversion · Acquired 778 · Balance 229,808 F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-08-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-14 · Exercise / conversion · Disposed 778 · Balance 0 F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. F2: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.
NETFLIX INC
Report date January 02, 2019 · Filed January 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $267.66 · Expires 2029-01-02 | Direct | 1,907 |
Reported balance
After 2019-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-01-02 · Grant · Acquired 1,907 · Balance 1,907 |
Trade Desk, Inc.
Report date May 13, 2025 · Filed May 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 66,985 |
Ending reported balance
After 2025-05-13 transaction · row 13
13 source rows · reconciled sequenceRow 1 · 2025-05-13 · Exercise / conversion · Acquired 6,990 · Balance 73,975 Row 2 · 2025-05-13 · Exercise / conversion · Acquired 1,390 · Balance 75,365 Row 3 · 2025-05-13 · Exercise / conversion · Acquired 670 · Balance 76,035 Row 4 · 2025-05-13 · Exercise / conversion · Acquired 220 · Balance 76,255 Row 5 · 2025-05-13 · Exercise / conversion · Acquired 6,826 · Balance 83,081 Row 6 · 2025-05-13 · Exercise / conversion · Acquired 1,365 · Balance 84,446 Row 7 · 2025-05-13 · Exercise / conversion · Acquired 655 · Balance 85,101 Row 8 · 2025-05-13 · Exercise / conversion · Acquired 218 · Balance 85,319 Row 9 · 2025-05-13 · Exercise / conversion · Acquired 7,282 · Balance 92,601 Row 10 · 2025-05-13 · Exercise / conversion · Acquired 1,374 · Balance 93,975 Row 11 · 2025-05-13 · Exercise / conversion · Acquired 1,374 · Balance 95,349 Row 12 · 2025-05-13 · Exercise / conversion · Acquired 274 · Balance 95,623 Row 13 · 2025-05-13 · Sale · Disposed 28,638 · Balance 66,985 F1: These sales represent the aggregate shares from the twelve acquisitions reported above. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.46 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2025-05-13 · Exercise / conversion · Disposed 6,990 · Balance 0 F3: This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F4: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.46 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2025-05-13 · Exercise / conversion · Disposed 1,390 · Balance 0 F5: This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F4: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.46 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2025-05-13 · Exercise / conversion · Disposed 670 · Balance 0 F6: This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F7: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.46 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2025-05-13 · Exercise / conversion · Disposed 220 · Balance 0 F8: This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. F9: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2032-05-26 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2025-05-13 · Exercise / conversion · Disposed 6,826 · Balance 0 F10: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2032-05-26 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2025-05-13 · Exercise / conversion · Disposed 1,365 · Balance 0 F10: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2032-05-26 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2025-05-13 · Exercise / conversion · Disposed 655 · Balance 0 F11: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2032-05-26 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · 2025-05-13 · Exercise / conversion · Disposed 218 · Balance 0 F12: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.26 · Expires 2033-05-25 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · 2025-05-13 · Exercise / conversion · Disposed 7,282 · Balance 0 F13: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.26 · Expires 2033-05-25 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · 2025-05-13 · Exercise / conversion · Disposed 1,374 · Balance 0 F13: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.26 · Expires 2033-05-25 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · 2025-05-13 · Exercise / conversion · Disposed 1,374 · Balance 0 F14: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.26 · Expires 2033-05-25 | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · 2025-05-13 · Exercise / conversion · Disposed 274 · Balance 0 F15: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
Filing footnotes · ownership attribution and instrument terms
F1: These sales represent the aggregate shares from the twelve acquisitions reported above.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F4: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F5: This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F6: This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F7: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
F8: This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
F9: The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
F10: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F11: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
F12: The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
F13: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
F14: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
F15: The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
Wise Group plc
Report date May 08, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Expires 2029-02-27 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-05-08 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F2: The initial exercise price for the option award was 0.6192 GBP. In connection with the effectiveness of the Issuer's Scheme of Arrangement on May 8, 2026, the option award was assumed by the Issuer and the exercise price thereof was converted from British pound sterling to U.S. dollars using a mid-market exchange rate on May 8, 2026, which is not yet available as of the time of this initial statement of beneficial ownership of securities. The Reporting Person undertakes to provide in a subsequent statement of changes in beneficial ownership full information regarding the exercise price for the option award following the conversion described above. F1: Fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Fully vested and exercisable.
F2: The initial exercise price for the option award was 0.6192 GBP. In connection with the effectiveness of the Issuer's Scheme of Arrangement on May 8, 2026, the option award was assumed by the Issuer and the exercise price thereof was converted from British pound sterling to U.S. dollars using a mid-market exchange rate on May 8, 2026, which is not yet available as of the time of this initial statement of beneficial ownership of securities. The Reporting Person undertakes to provide in a subsequent statement of changes in beneficial ownership full information regarding the exercise price for the option award following the conversion described above.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2022 Filed Jun 16, 2022 20:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000143 · wf-form4_165541190895317.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,336 Underlying: Class A Common Stock · 9,134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 20:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 893 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000143 · wf-form4_165541190895317.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,935 Underlying: Class A Common Stock · 893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 20:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000143 · wf-form4_165541190895317.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178 Underlying: Class A Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 20:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,045 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-22-000143 · wf-form4_165541190895317.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:37 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantStock Option (Right to Buy) · Derivative | 218 | $36.62 Strike: $49.03 | $7,983.16 |
DisclosureSEC source: 0001209191-22-032678 · doc4.xml · derivative · entry 5 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218 Underlying: Class A Common Stock · 218 shares Expires 2032-05-26 F5 · price: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. F9 · price: The option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $8,000. F8 · derivative.exercise_date: Grant of option to purchase Class A Common Stock under the Issuer's 2016 Equity Incentive Plan. The shares subject to the option vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:37 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantStock Option (Right to Buy) · Derivative | 655 | $36.62 Strike: $49.03 | $23,986.10 |
DisclosureSEC source: 0001209191-22-032678 · doc4.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655 Underlying: Class A Common Stock · 655 shares Expires 2032-05-26 F5 · price: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. F7 · price: The option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $24,000. F6 · derivative.exercise_date: Grant of option to purchase Class A Common Stock under the Issuer's 2016 Equity Incentive Plan. The shares subject to the option vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:37 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantStock Option (Right to Buy) · Derivative | 1,365 | $36.62 Strike: $49.03 | $49,986.30 |
DisclosureSEC source: 0001209191-22-032678 · doc4.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,365 Underlying: Class A Common Stock · 1,365 shares Expires 2032-05-26 F4 · price: The option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $50,000. F5 · price: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. F2 · derivative.exercise_date: Grant of option to purchase Class A Common Stock under the Issuer's 2016 Equity Incentive Plan. The shares subject to the option vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:37 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantStock Option (Right to buy) · Derivative | 6,826 | $0.00 Strike: $49.03 | $0.00 |
DisclosureSEC source: 0001209191-22-032678 · doc4.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,826 Underlying: Class A Common Stock · 6,826 shares Expires 2032-05-26 F3 · price: The option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant. F2 · derivative.exercise_date: Grant of option to purchase Class A Common Stock under the Issuer's 2016 Equity Incentive Plan. The shares subject to the option vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. Read SEC document |
| May 25, 2022 Filed May 27, 2022 21:37 UTC | Trade Desk, Inc. TTD · Entity 3752 | PurchaseClass A Common Stock | 17,500 | $45.81 | $801,675.00 |
DisclosureSEC source: 0001209191-22-032678 · doc4.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,570 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $45.74 to $45.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 23:14 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 9,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000095 · wf-form4_164755882586488.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,470 Underlying: Class A Common Stock · 9,133 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 23:14 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 894 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000095 · wf-form4_164755882586488.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,828 Underlying: Class A Common Stock · 894 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 23:14 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-22-000095 · wf-form4_164755882586488.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196 Underlying: Class A Common Stock · 17 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 23:14 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 10,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-22-000095 · wf-form4_164755882586488.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 71 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000085 · wf-form4_163979441182988.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213 Underlying: Class A Common Stock · 71 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 3,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000085 · wf-form4_163979441182988.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,722 Underlying: Class A Common Stock · 3,573 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 36,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-21-000085 · wf-form4_163979441182988.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,603 Underlying: Class A Common Stock · 36,534 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 40,178 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-21-000085 · wf-form4_163979441182988.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021. Read SEC document |
| August 18, 2021 Filed Aug 30, 2021 13:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | PurchaseClass A Common Stock | 50,000 | $7.27 | $363,335.00 |
DisclosureSEC source: 0001628280-21-017749 · wf-form4_163032936233259.xml · nonDerivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 F1 · date: The Reporting Person is hereby disclosing a delinquent Form 4. F5 · price: This transaction was executed in multiple trades at prices ranging from $7.2399 to $7.2899. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 17, 2021 Filed Aug 30, 2021 13:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | PurchaseClass A Common Stock | 60,000 | $7.20 | $431,916.00 |
DisclosureSEC source: 0001628280-21-017749 · wf-form4_163032936233259.xml · nonDerivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,000 F1 · date: The Reporting Person is hereby disclosing a delinquent Form 4. F4 · price: This transaction was executed in multiple trades at prices ranging from $7.15 to $7.24. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 16, 2021 Filed Aug 30, 2021 13:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | PurchaseClass A Common Stock | 50,000 | $7.78 | $388,940.00 |
DisclosureSEC source: 0001628280-21-017749 · wf-form4_163032936233259.xml · nonDerivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 F1 · date: The Reporting Person is hereby disclosing a delinquent Form 4. F3 · price: This transaction was executed in multiple trades at prices ranging from $7.7398 to $7.80 The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 13, 2021 Filed Aug 30, 2021 13:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | PurchaseClass A Common Stock | 200,000 | $8.91 | $1,781,000.00 |
DisclosureSEC source: 0001628280-21-017749 · wf-form4_163032936233259.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 F1 · date: The Reporting Person is hereby disclosing a delinquent Form 4. F2 · price: This transaction was executed in multiple trades at prices ranging from $8.87 to $8.94. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 10, 2021 Filed Feb 5, 2022 00:45 UTC | Trade Desk, Inc. TTD · Entity 3752 | GiftClass A Common Stock | 6,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007322 · doc5.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,070 F1 · kind: Bona fide gift not for value of Class A Common Stock to a charity. F2 · balance_after: On June 16, 2021, the Issuer effected a 10-for-1 stock split ("Stock Split") of its common stock resulting in the reporting person's ownership of 85,653 additional shares of common stock. Read SEC document |
| May 27, 2021 Filed Jun 2, 2021 00:20 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantStock Option (Right to Buy) · Derivative | 22 | $357.56 Strike: $584.58 | $7,866.32 |
DisclosureSEC source: 0001209191-21-036988 · doc4.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22 Underlying: Class A Common Stock · 22 shares Expires 2031-05-27 F4 · price: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. F8 · price: The option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $8,000. F7 · derivative.exercise_date: Grant of option to purchase Class A Common Stock under the Issuer's 2016 Equity Incentive Plan. The shares subject to the option vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. Read SEC document |
| May 27, 2021 Filed Jun 2, 2021 00:20 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantStock Option (Right to Buy) · Derivative | 67 | $357.56 Strike: $584.58 | $23,956.52 |
DisclosureSEC source: 0001209191-21-036988 · doc4.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67 Underlying: Class A Common Stock · 67 shares Expires 2031-05-27 F4 · price: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. F6 · price: The option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $24,000. F5 · derivative.exercise_date: Grant of option to purchase Class A Common Stock under the Issuer's 2016 Equity Incentive Plan. The shares subject to the option vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. Read SEC document |
| May 27, 2021 Filed Jun 2, 2021 00:20 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantStock Option (Right to Buy) · Derivative | 139 | $357.56 Strike: $584.58 | $49,700.84 |
DisclosureSEC source: 0001209191-21-036988 · doc4.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139 Underlying: Class A Common Stock · 139 shares Expires 2031-05-27 F3 · price: The option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $50,000. F4 · price: This price represents the Black-Scholes value of an option using the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of shares subject to the option granted. F1 · derivative.exercise_date: Grant of option to purchase Class A Common Stock under the Issuer's 2016 Equity Incentive Plan. The shares subject to the option vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. Read SEC document |
| May 27, 2021 Filed Jun 2, 2021 00:20 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantStock Option (Right to buy) · Derivative | 699 | $0.00 Strike: $584.58 | $0.00 |
DisclosureSEC source: 0001209191-21-036988 · doc4.xml · derivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 699 Underlying: Class A Common Stock · 699 shares Expires 2031-05-27 F2 · price: The option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant. F1 · derivative.exercise_date: Grant of option to purchase Class A Common Stock under the Issuer's 2016 Equity Incentive Plan. The shares subject to the option vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:26 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 284 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014239 · doc4.xml · derivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284 Underlying: Class A Common Stock · 284 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 14,295 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003093 · doc4.xml · derivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,295 Underlying: Class A Common Stock · 14,295 shares Expires not disclosed F3 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs"). F4 · derivative.exercise_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 2 above. Additionally, the Earn Out RSUs will vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the RSU Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited. F4 · derivative.expiration_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 2 above. Additionally, the Earn Out RSUs will vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the RSU Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited. Read SEC document |
| January 20, 2021 Filed Jan 23, 2021 02:28 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 146,137 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003093 · doc4.xml · derivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,137 Underlying: Class A Common Stock · 146,137 shares Expires not disclosed F1 · derivative.exercise_price: In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs"). F2 · derivative.exercise_date: The New Hims RSUs were received in exchange for 322,613 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period commencing in December 2020, with 25% vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with Him News. The New Hims RSUs expire is November 2027. F2 · derivative.expiration_date: The New Hims RSUs were received in exchange for 322,613 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period commencing in December 2020, with 25% vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with Him News. The New Hims RSUs expire is November 2027. Read SEC document |
| November 16, 2020 Filed Feb 13, 2021 00:46 UTC | Trade Desk, Inc. TTD · Entity 3752 | GiftClass A Common Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010473 · doc5.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,517 F1 · kind: Bona fide gift not for value of Class A Common Stock to a charity. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 21:50 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,840 | $0.00 Strike: $54.52 | $0.00 |
DisclosureSEC source: 0001209191-20-038564 · doc4.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,840 shares Expires 2027-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on July 20, 2017, (the "Grant Date"). The shares vested in quarterly installments over the one-year period following the Grant Date with the exception of the last quarterly installment which, per the vesting schedule, vested in full on May 3, 2018, the date of Issuer's 2018 annual meeting of stockholders. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 21:50 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass A Common Stock | 2,840 | $400.00 | $1,136,000.00 |
DisclosureSEC source: 0001209191-20-038564 · doc4.xml · nonDerivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,617 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 21:50 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 2,840 | $54.52 | $154,836.80 |
DisclosureSEC source: 0001209191-20-038564 · doc4.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 22:46 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,639 | $0.00 Strike: $54.52 | $0.00 |
DisclosureSEC source: 0001209191-20-034812 · doc4.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,639 shares Expires 2027-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on July 20, 2017, (the "Grant Date"). The shares vested in quarterly installments over the one-year period following the Grant Date with the exception of the last quarterly installment which, per the vesting schedule, vested in full on May 3, 2018, the date of Issuer's 2018 annual meeting of stockholders. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 22:46 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass A Common Stock | 6,639 | $350.00 | $2,323,650.00 |
DisclosureSEC source: 0001209191-20-034812 · doc4.xml · nonDerivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,617 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 22:46 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass A Common Stock | 6,639 | $54.52 | $361,958.28 |
DisclosureSEC source: 0001209191-20-034812 · doc4.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2020 Filed May 29, 2020 00:34 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantClass A Common Stock | 32 | $249.66 | $7,989.12 |
DisclosureSEC source: 0001209191-20-032799 · doc4.xml · nonDerivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,617 F7 · shares: Grant of restricted stock award under the Issuer's 2016 Equity Incentive Plan. The shares vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. F4 · price: This price represents the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of restricted stock awards granted. F8 · price: This restricted stock award was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $8,000. Read SEC document |
| May 26, 2020 Filed May 29, 2020 00:34 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantClass A Common Stock | 96 | $249.66 | $23,967.36 |
DisclosureSEC source: 0001209191-20-032799 · doc4.xml · nonDerivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,585 F5 · shares: Grant of restricted stock award under the Issuer's 2016 Equity Incentive Plan. The shares vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. F4 · price: This price represents the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of restricted stock awards granted. F6 · price: This restricted stock award was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $24,000. Read SEC document |
| May 26, 2020 Filed May 29, 2020 00:34 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantClass A Common Stock | 180 | $249.66 | $44,938.80 |
DisclosureSEC source: 0001209191-20-032799 · doc4.xml · nonDerivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,489 F1 · shares: Grant of restricted stock award under the Issuer's 2016 Equity Incentive Plan. The shares vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. F3 · price: This restricted stock award was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of director retainer and meeting fees of $45,000. F4 · price: This price represents the average closing stock price for a share of the Issuer's Class A Common Stock for forty-five consecutive trading days ending on, and including, the grant date. This price was used to calculate the number of restricted stock awards granted. Read SEC document |
| May 26, 2020 Filed May 29, 2020 00:34 UTC | Trade Desk, Inc. TTD · Entity 3752 | GrantClass A Common Stock | 901 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032799 · doc4.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,309 F1 · shares: Grant of restricted stock award under the Issuer's 2016 Equity Incentive Plan. The shares vest in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares shall vest in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. F2 · price: This restricted stock award was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy as an annual director equity grant. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 23:27 UTC | Trade Desk, Inc. TTD · Entity 3752 | ConversionClass B Common Stock · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007027 · doc4.xml · derivative · entry 5 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. F3 · derivative.expiration_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 23:27 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass B Common Stock · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007027 · doc4.xml · derivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Class A Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. F3 · derivative.expiration_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 23:27 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.36 | $0.00 |
DisclosureSEC source: 0001209191-20-007027 · doc4.xml · derivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 5,000 shares Expires 2025-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on December 20, 2015, (the "Grant Date"). One-fourth (1/4th) of the shares subject to the option vest on the first anniversary of the Grant Date, with one forty-eighth (1/48th ) of the shares subject to the original grant vesting on each monthly anniversary thereafter, subject to continued service as a director of the Issuer through the applicable vesting dates. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 23:27 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass A Common Stock | 5,000 | $300.00 | $1,500,000.00 |
DisclosureSEC source: 0001209191-20-007027 · doc4.xml · nonDerivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,408 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 23:27 UTC | Trade Desk, Inc. TTD · Entity 3752 | ConversionClass A Common Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007027 · doc4.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC | Trade Desk, Inc. TTD · Entity 3752 | ConversionClass B Common Stock · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · derivative · entry 9 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. F8 · derivative.expiration_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionClass B Common Stock · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · derivative · entry 8 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. F8 · derivative.expiration_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC | Trade Desk, Inc. TTD · Entity 3752 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.36 | $0.00 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · derivative · entry 7 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Class B Common Stock · 10,000 shares Expires 2025-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option was granted on December 20, 2015, (the "Grant Date"). One-fourth (1/4th) of the shares subject to the option vest on the first anniversary of the Grant Date, with one forty-eighth (1/48th ) of the shares subject to the original grant vesting on each monthly anniversary thereafter, subject to continued service as a director of the Issuer through the applicable vesting dates. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass A Common Stock | 1,900 | $283.48 | $538,612.00 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · nonDerivative · entry 6 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,408 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.24 to $283.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC | Trade Desk, Inc. TTD · Entity 3752 | SaleClass A Common Stock | 2,636 | $282.56 | $744,828.16 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · nonDerivative · entry 5 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,308 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.17 to $282.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.